Clinical Trials Browser

Phase 1 × HER-2 Gene Amplification × Trastuzumab × Clear all

NCT01304784 2015-12-16

A Study of MM-111 in Combination With Multiple Treatments in Patients With HER2 Positive Cancer

Phase 1 Completed

HER-2 Gene Amplification